2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

Alvarez-Vázquez, A, San-Segundo, L, Cerveró-García, P, Flores-Hernández, R, Ollauri-Ibáñez, C, Segura-Collar, B, Hubert, CG, Morrison, G, Pollard, SM, Lathia, JD, Sánchez-Gómez, P, Tabernero, A. EGFR amplification and EGFRvIII predict and participate in TAT-Cx43_266-283 antitumor response in preclinical glioblastoma models. NEURO-ONCOLOGY 26 1230-1246. 20 mar 2024. 1 mar 2024. . F.I.:16,400 [doi:10.1093/neuonc/noae060]